Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
Holzhaeuser, E.; Berlin, M.; Wollschlaeger, D. et al.
Patterns of failure of Diffuse Large B-Cell Lymphoma (DLBCL) patients after Involved Site Radiotherapy (ISRT)STRAHLENTHERAPIE UND ONKOLOGIE. Bd. 193. 2017 S. S5-S5
Holzhaeuser, Eva; Berlin, Maximilian; Wollschlger, Daniel et al.
Patterns of failure of diffuse large BaEurocell lymphoma patients after involved-site radiotherapySTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 193. H. 12. 2017 S. 1014-1023
Dinkic, C.; Eichbaum, M.; Schmidt, M. et al.
Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant,recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trialGYNECOLOGIC ONCOLOGY. Bd. 146. H. 2. 2017 S. 279-284
Kalasauskas, D; Renovanz, M; Bikar, S et al.
Perspectives and Challenges in Molecular-Based Diagnostics and PersonalizedCarcinogenesis and Mutagenesis. 2017 S. 1000290
Borchmann, Peter; Goergen, Helen; Kobe, Carsten et al.
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study GroupLANCET. Bd. 390. H. 10114. 2017 S. 2790-2802
Rades, Dirk; Maderer, Annett; Panzner, Annika et al.
Phase I Study of Definitive Radio-chemotherapy with Cisplatin, 5-Fluorouracil and Cetuximab for Unresectable Locally Advanced Esophageal CancerANTICANCER RESEARCH. Bd. 37. H. 5. 2017 S. 2703-2708
Moehler, Markus; Mahlberg, Rolf; Heinemann, Volker et al.
Phase I study of orally administered S-1 in combination with epirubicin and oxaliplatin in patients with advanced solid tumors and chemotherapy-naive advanced or metastatic esophagogastric cancerGASTRIC CANCER. Bd. 20. H. 2. 2017 S. 358-367
Bug, G.; Burchert, A.; Wagner, E-M et al.
Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)LEUKEMIA. Bd. 31. H. 11. 2017 S. 2523-2525
Einsele, Hermann; Engelhardt, Monika; Tapprich, Christoph et al.
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trialBRITISH JOURNAL OF HAEMATOLOGY. Bd. 179. H. 4. 2017 S. 586-597
Zeissig, S.; Grabbe, S.
Pilot Study for the Registration of non-melanotic Skin Tumors in the Cancer Registry of Rhineland-PalatinateJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 15. 2017 S. 65-66